Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
New drug regimen for Helicobacter pylori eradication, the investigators compare once daily
dose dexlansoprazole levofloxacin based quadruple therapy and twice daily dose
dexlansoprazole levofloxacin quadruple therapy for helicobacter pylori eradication.